Xeris Pharmaceuticals Inc (XERS)

$7.18 -0.08 (-1.10%)
Market Cap 1.20B
Revenue (ttm) 203.07M
Net Income (ttm) -54.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.01%
Debt to Equity Ratio -255.20
Volume 2,961,200
Avg Vol 2,518,618
Day's Range N/A - N/A
Shares Out 165.92M
Stochastic %K 6%
Beta 0.21
Analysts Strong Sell
Price Target $11.50

Company Profile

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 445 5704
Address:
1375 West Fulton Street, Suite 1300, Chicago, United States
Lehto08
Lehto08 Nov. 14 at 10:37 PM
$XERS I was waiting for a good DCA point, now I have it
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 8:51 PM
💎 LiquidTheta® Live Actionable Trade Asset: $XERS Contracts: $XERS April 17, 2026 $8 Calls Scale in: $1.19- $1.46 Scale out: $4.64-$7.95 Profit Potential : 181% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Finwizard61
Finwizard61 Nov. 14 at 8:48 PM
$XERS Picked up another 200 shares at $7.15..
0 · Reply
columbusmike
columbusmike Nov. 14 at 8:42 PM
$XERS
0 · Reply
Struin
Struin Nov. 14 at 8:23 PM
$XERS https://www.hln.be/gezondheid/nieuw-medicijn-tegen-diabetes-type-1-goedgekeurd-endocrinoloog-nieuw-tijdperk-is-aangebroken~a7da470a/
0 · Reply
Struin
Struin Nov. 14 at 8:18 PM
$XERS Sorry were all the guys who'crying 11, 12 16 20 dollar THEY ALL SUDDENLY DISAPPEARED HERE
2 · Reply
LurkerBoy
LurkerBoy Nov. 14 at 8:03 PM
$XERS Not even XBI can hold this up. 5.s coming very soon.
1 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:48 PM
$XERS wow candle
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:46 PM
$XERS make me put my foot in mouth please!
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:34 PM
$XERS fing xbi up 2 5 percent and this turd down again 2 fuck#$$ percent
0 · Reply
Latest News on XERS
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:16 AM EST - 8 days ago

Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call Transcript

Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025

Nov 6, 2025, 7:00 AM EST - 8 days ago

Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025

Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 7:30 AM EDT - 22 days ago

Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 3, 2025, 4:15 PM EDT - 6 weeks ago

Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy

Sep 5, 2025, 10:03 AM EDT - 2 months ago

Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy

Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®

Aug 25, 2025, 7:00 AM EDT - 2 months ago

Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®

Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:38 PM EDT - 3 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call Transcript

Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance

Aug 7, 2025, 7:00 AM EDT - 3 months ago

Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance

Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 31, 2025, 7:30 AM EDT - 3 months ago

Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025

Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing

Jun 18, 2025, 10:17 AM EDT - 5 months ago

Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

Jun 3, 2025, 7:30 AM EDT - 5 months ago

Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day

Xeris Announces Details for Analyst & Investor Day

May 20, 2025, 7:30 AM EDT - 6 months ago

Xeris Announces Details for Analyst & Investor Day

Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript

May 8, 2025, 2:15 PM EDT - 6 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

May 8, 2025, 7:00 AM EDT - 6 months ago

Xeris Biopharma Reports Record First Quarter 2025 Financial Results

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

May 7, 2025, 11:51 AM EDT - 6 months ago

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 7:00 AM EDT - 7 months ago

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Xeris Announces Changes to Its Board of Directors

Mar 28, 2025, 8:00 AM EDT - 8 months ago

Xeris Announces Changes to Its Board of Directors

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Mar 17, 2025, 8:00 AM EDT - 8 months ago

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Xeris Biopharma Holdings, Inc. (XERS) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 10:52 AM EST - 9 months ago

Xeris Biopharma Holdings, Inc. (XERS) Q4 2024 Earnings Call Transcript

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Mar 6, 2025, 7:00 AM EST - 9 months ago

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Feb 27, 2025, 7:00 AM EST - 9 months ago

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Feb 24, 2025, 8:00 AM EST - 9 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

Xeris to Participate in Upcoming Investor Conferences

Feb 5, 2025, 8:00 AM EST - 10 months ago

Xeris to Participate in Upcoming Investor Conferences

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Jan 21, 2025, 9:00 AM EST - 10 months ago

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Jan 10, 2025, 7:00 AM EST - 11 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jan 6, 2025, 4:15 PM EST - 11 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 7:00 AM EST - 1 year ago

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 11:50 AM EST - 1 year ago

Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 7:00 AM EST - 1 year ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive

Oct 25, 2024, 12:50 PM EDT - 1 year ago

Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive

Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips +

Oct 11, 2024, 2:00 PM EDT - 1 year ago

Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips +

GNRC KLC PHG

Xeris Biopharma: Time For A Reassessment

Oct 9, 2024, 11:33 AM EDT - 1 year ago

Xeris Biopharma: Time For A Reassessment

Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 11:56 AM EDT - 1 year ago

Xeris Biopharma Holdings, Inc. (XERS) Q2 2024 Earnings Call Transcript

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Jul 25, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

Xeris Biopharma Announces CEO Succession Plan

Jul 8, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Announces CEO Succession Plan

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

May 30, 2024, 7:30 AM EDT - 1 year ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris to Participate in the Jefferies Global Healthcare Conference

May 30, 2024, 7:00 AM EDT - 1 year ago

Xeris to Participate in the Jefferies Global Healthcare Conference

Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript

May 9, 2024, 12:49 PM EDT - 1 year ago

Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

May 9, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics

May 6, 2024, 7:00 AM EDT - 1 year ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

May 2, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Apr 3, 2024, 4:05 PM EDT - 1 year ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Mar 30, 2024, 1:28 AM EDT - 1 year ago

Xeris Biopharma: Checking-In On One Of My 'Top Ideas'

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 12:43 PM EST - 1 year ago

Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Mar 6, 2024, 7:02 AM EST - 1 year ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Mar 6, 2024, 7:00 AM EST - 1 year ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Lehto08
Lehto08 Nov. 14 at 10:37 PM
$XERS I was waiting for a good DCA point, now I have it
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 8:51 PM
💎 LiquidTheta® Live Actionable Trade Asset: $XERS Contracts: $XERS April 17, 2026 $8 Calls Scale in: $1.19- $1.46 Scale out: $4.64-$7.95 Profit Potential : 181% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Finwizard61
Finwizard61 Nov. 14 at 8:48 PM
$XERS Picked up another 200 shares at $7.15..
0 · Reply
columbusmike
columbusmike Nov. 14 at 8:42 PM
$XERS
0 · Reply
Struin
Struin Nov. 14 at 8:23 PM
$XERS https://www.hln.be/gezondheid/nieuw-medicijn-tegen-diabetes-type-1-goedgekeurd-endocrinoloog-nieuw-tijdperk-is-aangebroken~a7da470a/
0 · Reply
Struin
Struin Nov. 14 at 8:18 PM
$XERS Sorry were all the guys who'crying 11, 12 16 20 dollar THEY ALL SUDDENLY DISAPPEARED HERE
2 · Reply
LurkerBoy
LurkerBoy Nov. 14 at 8:03 PM
$XERS Not even XBI can hold this up. 5.s coming very soon.
1 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:48 PM
$XERS wow candle
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:46 PM
$XERS make me put my foot in mouth please!
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:34 PM
$XERS fing xbi up 2 5 percent and this turd down again 2 fuck#$$ percent
0 · Reply
BuyThisOne
BuyThisOne Nov. 14 at 7:19 PM
$XERS easy come easy go Kinda hoping for $5 again so I can add more for long term and some for a short term play and maybe 4x my money in a year or so.
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 7:01 PM
$XERS say by by to 7
1 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 6:51 PM
$XERS This queen with his songs doesn't do shit for any serious investors. Wtf blocked!
0 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 6:48 PM
$XERS repeating piece of dog s×$T! ... Guess I'll buy more
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:19 PM
Hedge Alert Live - Protect Your Portfolio Contract: $XERS $5.00 Put · NOV 21, 2025 Exp Entry Price: $0.15 - $0.75 Exit Price Target: $0.25 Profit Margin: +66% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
dave2ta
dave2ta Nov. 14 at 5:28 PM
$XERS My Latest Album, "Finding Life" has just been released this morning to ALL the Digital Music Platforms, including Spotify, Apple Music & iTunes, Pandora, SoundCloud, and over 80 more. The Weekend is coming, so find a comfortable place and listen to some Great Music... Here is a link for SoundCloud. If it doesn't work for you, go to another Platform and search for Dave Evans Solo, it will be there. https://soundcloud.com/daveevanssolo/sets/finding-life
2 · Reply
TheCatInTheHat1
TheCatInTheHat1 Nov. 14 at 5:09 PM
$XERS Don't make me buy more. F the charts. This acts irrationally
0 · Reply
ForTGTX
ForTGTX Nov. 14 at 3:49 PM
$XERS I’m a long-term bio stock holder so I don’t worry about daily charts. XERS will be a great bio company with blockbuster drugs in 4-5 years.
0 · Reply
10sense
10sense Nov. 14 at 3:11 PM
$XERS
0 · Reply
beelzebubba
beelzebubba Nov. 14 at 2:47 PM
$XERS -Price target increased by 7.8% to $11.50 from $10.67 (an average from 6 analysts). -New target price is 58% above last closing price of US$7.26. -Stock is up 138% over the past year. I'm not going anywhere.
2 · Reply
BuyThisOne
BuyThisOne Nov. 14 at 2:34 PM
$XERS looks like there might be time to sell before the bottom here if that's your thing.
0 · Reply
therealpoub
therealpoub Nov. 14 at 2:31 PM
$XERS while we wait to see all the 13F's yesterday had some nice additions. The numbers don't lie.
1 · Reply